| Catalog Number |
310620 |
| Medical Device Problem Code |
False Positive Result (1227)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
03/12/2024
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Review of the information reasonably known at the time of reporting indicates that no death or patient injury, illness, life threatening condition, permanent impairment, permanent damage to a body structure, or medical or surgical intervention to prevent permanent impairment or damage occurred (definition of serious injury 21 cfr 803.3).Data review, complaint history, and trend analysis for the liaison® hsv-2 type specific igg assay did not identify evidence of a product quality or performance issue.If a false positive were to occur, it is unlikely to cause death or serious injury.The manufacturer is conservatively submitting this report.
|
| |
|
Event or Problem Description
|
|
Diasorin received a voluntary medwatch report alleging a false positive result generated by the diasorin liaison® xl hsv 2 igg assay performed by an external laboratory.According to the report, the patient tested positive by the liaison® xl hsv-2 type specific igg assay and positive by the external laboratory's inhibition assay.Confirmatory test (test type and site unknown) was negative.No adverse clinical outcomes were reported.
|
| |
|
Event or Problem Description
|
|
Confirmatory test, (b)(4).Blot test date (b)(6) 2024.
|
| |
|
Search Alerts/Recalls
|